The BRS 2025 annual meeting will attract around 200 delegates from across the country and beyond. Exhibiting at our meeting will give you access to leading experts in the field of Bone Research. The exhibition will be held in the refreshment area and alongside the poster hall and main plenary room at the John McIntrye Conference Centre.
As the exhibition and catering are integrated this will allow for a central area for networking.
Imaging Workshop - Wednesday 25 June 2025 (14:00-17:00) - Roslin Institute - Sponsored by Wonderful Scientific
13.00 - Coach departs from JMCC to Roslin Institute
13.30 - 14.00 - Lunch and welcome
14.00 - 14.10 - Welcome to Roslin Bioimaging by Louise Stephen and Ann Wheeler
14.10 - 14.20 - µCT analysis in mouse models of renal osteodystrophy - Worachet Promruk
14.20 - 15.20 - Tour of Roslin imaging capabilities
15.20 - 15.45 - Refreshments
15.45 - 16.05 - Chicken limb development – Megan Davey
16.05 - 16.25 - Zebrafish Skeletons: A Bone-anza of Fun – Erika Kague
16.25 - 16.55 - Opportunities for studying bone in large animal models at LARIF – Carola Daniel
17:00 - Return coach transfer departs to JMCC
UCB Promotional Symposium - Wednesday 25 June 2025 (17:45-18:15) - JMCC
Accelerating the Urgency of Care For post-menopausal Patients with severe osteoporosis - Professor Ken Poole, Addenbrookes
This session is intended for UK and ROI Healthcare Professionals only
Alexion - Sponsored Satellite Symposium - Thursday 26 June 2025 (14:00-14:45) - JMCC
(related to Rare Bone Disease)
ReThink HPP: From skeletal abnormalities to systemic diagnosis - Dr Judith Bubbear, Consultant Rheumatologist & Metabolic Bone Diseases
This symposium is organized and funded by Alexion, AstraZeneca Rare Diseases UK and is intended for healthcare professionals only
Theramex - Sponsored Satellite Symposium - Friday 27 June 2025 (11:00-11:30) - JMCC
Chaired by Dr Barbara Hauser who is a Consultant Rheumatologist with a specialist interest in osteoporosis and metabolic bone disease. She also serves as an Honorary Senior Lecturer at the University of Edinburgh.
Speaker: Professor David Reid MBE, Consultant Rheumatologist with a specialist interest in osteoporosis and Emeritus Professor of Rheumatology, University of Aberdeen.
This symposium is organised and funded by Theramex, and is intended for Healthcare Professionals only.
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialisation of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.
We are Theramex, a global speciality pharmaceutical company solely committed to supporting the health needs of women through every stage of life. We work on patient-focused, effective solutions that support women of all ages.
We work closely with our partners, healthcare professionals, and patients to provide women with the right solution, at the time they most need it.
We believe in empowering women to make informed decisions about how to manage the natural cycles and stages of their life. To do this, we provide education and support around contraception, endometriosis, fertility, menopause, osteoporosis and uterine fibroids.
www.theramex.com/uk/
We are UCB, a global biopharmaceutical company dedicated to discovering and developing treatments that aim to transform the lives of people living with neurological and immunological conditions, as well as rare diseases.
For further information regarding our company, please visit www.ucbpharma.co.uk
Founded in 2007, Ascendis Pharma is applying its innovative TransCon™ technology platform to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we use our TransCon technologies to fulfill our mission of developing new and potentially best-in-class therapies that address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit www.ascendispharma.com to learn more.
Founded in 2013, BlueScientific is a trusted distributor of cutting-edge surface and materials science instruments across the UK, Ireland, Netherlands and Nordic region.
We partner with industry-leading manufacturers to deliver instruments that can be applied across key sectors such as batteries, geology and mining, art conservation, pharmaceuticals, and surface science.
The solutions we distribute provide our customers with the best chance of application success, helping them get the maximum value from their instrument investment.
The highly skilled BlueScientific team are committed to delivering technical solutions and added value to customers throughout the entire lifecycle of their instruments, from initial installation and training to ongoing service support.
BlueScientific is the official distributor of Bruker's range of micro-CT/XRM systems.
Bruker’s portfolio of 3D X-ray microCT systems offers turnkey solutions for non-destructive, high resolution 3D imaging of small laboratory animals and a wide variety biological samples. This includes mineralized and soft tissues, tumours, plants and insects, as well as archaeological and paleontological research fields.
Micro-computed tomography (microCT) or X-Ray Microscopy (XRM) is X-ray imaging in 3D, the same method used in clinical CT scans, but on a small scale with massively increased resolution. It really represents 3D microscopy, where very fine scale internal structure of objects is imaged non-destructively, both in vivo and ex vivo. Bruker micro- and nano-tomography is available in a range of easy-to-use desktop and floor standing instruments, which generate 3D images of your sample’s morphology and internal microstructure with resolutions down to micron and even sub-micron level.
Our website is www.blue-scientific.com
Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential to help patients with high unmet medical needs.
We bring humility, creativity and a relentless passion to achieve our purpose: to make people smile.
We are Wonderful Scientific, a sales and consulting company specialising in scientific and clinical imaging scanners.
Wonderful Scientific is the proud distributor of NeoScan.com benchtop Micro-CT and Nano-CT products in the UK and Ireland. We are committed to providing the highest quality instruments to our customers.
NeoScan scanners are the most advanced and innovative in the market. The recently launched N90 is the world’s first bench-top Nano-CT and has 300nm spatial and 40nm voxel size at maximum resolution.
The N80 scanner is the best in class scanner and is ideal for high resolution bone analysis and visualisation. The N80 has a sealed transmission X-ray source with a 2um spot size and movable target repositioning, radiation hardened camera protection, 2:1 fibre optics, active artefact suppression, new precision stepper motors and all new software. The resulting benefits make it the most robust, long lasting, scientific grade bench-top Micro-CT on the market today.
Our website is www.wonderfulscientific.com
We’re the Royal Osteoporosis Society – the UK’s largest national charity dedicated to improving bone health and beating osteoporosis. We’re here for everyone. We equip people with practical information and support to take action on their bone health.
Working with healthcare professionals and policy-makers, we’re influencing and shaping policy and practice at every level.
We focus our efforts on what's best for the person and what makes the biggest difference to their lives. We always see the individual, not the condition.
Our work covers every aspect of osteoporosis, we:
**NEW for 2025 - BoneMed Online:
Free 12 month digital medicine support programme to:
For more information about the sponsorship packages which are available please click HERE
Should you have any questions at all sponsorship and exhibiting opportiunities, please contact the BRS Event Team:
events@boneresearchsociety.org
